🇺🇸 FDA
Patent

US 10080749

Multi-drug therapies for tuberculosis treatment

granted A61KA61K31/133A61K31/44

Quick answer

US patent 10080749 (Multi-drug therapies for tuberculosis treatment) held by The Regents of the University of California expires Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/133, A61K31/44, A61K31/47, A61K31/4965